Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunisation against hepatitis B.

I D Gust, C R Lucas

    Australian Family Physician
    |September 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Viral hepatitis is caused by multiple agents. A new hepatitis B vaccine is available in Australia, offering a safe and effective way to control this disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

    Biologicals : journal of the International Association of Biological Standardization·2010
    Same author

    Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007.

    Biologicals : journal of the International Association of Biological Standardization·2008
    Same author

    A global lab against influenza.

    Science (New York, N.Y.)·2001
    Same author

    Planning for the next pandemic of influenza.

    Reviews in medical virology·2001
    Same author

    Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.

    The New Zealand medical journal·2000
    Same author

    Hepatitis B infection in households of HBsAg positive New Zealand children.

    The New Zealand medical journal·1996
    Same journal

    Occupational violence and staff safety in general practice.

    Australian family physician·2018
    Same journal

    You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

    Australian family physician·2018
    Same journal

    Understanding the decision to commence a dose administration aid.

    Australian family physician·2018
    Same journal

    Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

    Australian family physician·2018
    Same journal

    A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

    Australian family physician·2018
    Same journal

    The Australian Mid-West Coastal Marine Wound Infections Study.

    Australian family physician·2018
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Viral hepatitis is a significant public health concern, recognized to be caused by at least three distinct viral agents.
    • Hepatitis A virus (HAV) and Hepatitis B virus (HBV) have been identified and characterized.
    • Hepatitis B poses a substantial disease burden globally and in Australia.

    Purpose of the Study:

    • To highlight the identification and characterization of major viral hepatitis agents.
    • To introduce the availability and significance of a new hepatitis B vaccine.

    Main Methods:

    • Literature review and scientific consensus on viral hepatitis agents.
    • Description of vaccine development and characterization of hepatitis B virus.
    • Assessment of vaccine availability and efficacy in Australia.

    Related Experiment Videos

    Main Results:

    • Two primary causative agents of viral hepatitis, Hepatitis A and Hepatitis B, have been identified.
    • A safe and effective subunit vaccine for Hepatitis B is now available.
    • The vaccine is expected to significantly aid in the control of Hepatitis B in Australia.

    Conclusions:

    • The identification of hepatitis viruses has advanced understanding of the disease.
    • The availability of a safe and effective Hepatitis B vaccine marks a significant milestone in disease control.
    • Widespread vaccination is anticipated to reduce the incidence and impact of Hepatitis B.